批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/06/07 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/07/12 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/01/30 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/05/10 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/07/28 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/01/14 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/03/27 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/05/08 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/08/23 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/07/15 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/03/01 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/08/31 |
SUPPL-6(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2010/07/13 |
SUPPL-1(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/02/19 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:PRAMIPEXOLE DIHYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:0.375MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022421 |
001 |
NDA |
MIRAPEX ER |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Discontinued |
Yes |
No |
AB |
2010/02/19
|
BOEHRINGER INGELHEIM |
202206 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Discontinued |
No |
No |
AB |
2014/02/06
|
ENDO OPERATIONS |
202353 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Prescription |
No |
No |
AB |
2014/12/04
|
SANDOZ |
203354 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Prescription |
No |
Yes |
AB |
2015/08/07
|
DR REDDYS |
201963 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Prescription |
No |
No |
AB |
2016/04/21
|
ACTAVIS ELIZABETH |
206156 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Prescription |
No |
No |
AB |
2016/06/24
|
MACLEODS PHARMS LTD |
202891 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Prescription |
No |
No |
AB |
2017/12/12
|
ZYDUS PHARMS |
204518 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Prescription |
No |
No |
AB |
2019/01/02
|
ALEMBIC |
212797 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Prescription |
No |
No |
AB |
2021/06/11
|
XIAMEN LP PHARM CO |
213444 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.375MG |
Prescription |
No |
No |
AB |
2022/02/03
|
NOVAST LABS |
活性成分:PRAMIPEXOLE DIHYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:0.75MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022421 |
002 |
NDA |
MIRAPEX ER |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Discontinued |
Yes |
No |
AB |
2010/02/19
|
BOEHRINGER INGELHEIM |
202206 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Discontinued |
No |
No |
AB |
2014/02/06
|
ENDO OPERATIONS |
202353 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Prescription |
No |
No |
AB |
2014/12/04
|
SANDOZ |
203354 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Prescription |
No |
No |
AB |
2015/08/07
|
DR REDDYS |
201963 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Prescription |
No |
No |
AB |
2016/04/21
|
ACTAVIS ELIZABETH |
206156 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Prescription |
No |
No |
AB |
2016/06/24
|
MACLEODS PHARMS LTD |
202891 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Prescription |
No |
No |
AB |
2017/12/12
|
ZYDUS PHARMS |
204518 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Prescription |
No |
No |
AB |
2019/01/02
|
ALEMBIC |
212797 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Prescription |
No |
No |
AB |
2021/06/11
|
XIAMEN LP PHARM CO |
213444 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
0.75MG |
Prescription |
No |
No |
AB |
2022/02/03
|
NOVAST LABS |
活性成分:PRAMIPEXOLE DIHYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:1.5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022421 |
003 |
NDA |
MIRAPEX ER |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Discontinued |
Yes |
No |
AB |
2010/02/19
|
BOEHRINGER INGELHEIM |
202206 |
003 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Discontinued |
No |
No |
AB |
2014/02/06
|
ENDO OPERATIONS |
202353 |
003 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Prescription |
No |
No |
AB |
2014/12/04
|
SANDOZ |
203354 |
003 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Prescription |
No |
No |
AB |
2015/08/07
|
DR REDDYS |
201963 |
003 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Prescription |
No |
No |
AB |
2016/04/21
|
ACTAVIS ELIZABETH |
206156 |
003 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Prescription |
No |
No |
AB |
2016/06/24
|
MACLEODS PHARMS LTD |
202891 |
003 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Prescription |
No |
No |
AB |
2017/12/12
|
ZYDUS PHARMS |
204518 |
003 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Prescription |
No |
No |
AB |
2019/01/02
|
ALEMBIC |
213444 |
003 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
1.5MG |
Prescription |
No |
No |
AB |
2022/02/03
|
NOVAST LABS |
活性成分:PRAMIPEXOLE DIHYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:3MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022421 |
004 |
NDA |
MIRAPEX ER |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Discontinued |
Yes |
No |
AB |
2010/02/19
|
BOEHRINGER INGELHEIM |
202206 |
005 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Discontinued |
No |
No |
AB |
2014/02/06
|
ENDO OPERATIONS |
202353 |
004 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Prescription |
No |
No |
AB |
2014/12/04
|
SANDOZ |
203354 |
004 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Prescription |
No |
No |
AB |
2015/08/07
|
DR REDDYS |
201963 |
004 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Prescription |
No |
No |
AB |
2016/04/21
|
ACTAVIS ELIZABETH |
206156 |
005 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Prescription |
No |
No |
AB |
2016/06/24
|
MACLEODS PHARMS LTD |
202891 |
005 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Prescription |
No |
No |
AB |
2017/12/12
|
ZYDUS PHARMS |
204518 |
005 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Prescription |
No |
No |
AB |
2019/01/02
|
ALEMBIC |
213444 |
005 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3MG |
Prescription |
No |
No |
AB |
2022/02/03
|
NOVAST LABS |
活性成分:PRAMIPEXOLE DIHYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:4.5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022421 |
005 |
NDA |
MIRAPEX ER |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Discontinued |
Yes |
No |
AB |
2010/02/19
|
BOEHRINGER INGELHEIM |
202206 |
007 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Discontinued |
No |
No |
AB |
2014/02/06
|
ENDO OPERATIONS |
202353 |
005 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Prescription |
No |
No |
AB |
2014/12/04
|
SANDOZ |
203354 |
005 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Prescription |
No |
No |
AB |
2015/08/07
|
DR REDDYS |
201963 |
005 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Prescription |
No |
No |
AB |
2016/04/21
|
ACTAVIS ELIZABETH |
206156 |
006 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Prescription |
No |
No |
AB |
2016/06/24
|
MACLEODS PHARMS LTD |
202891 |
007 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Prescription |
No |
No |
AB |
2017/12/12
|
ZYDUS PHARMS |
204518 |
007 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Prescription |
No |
No |
AB |
2019/01/02
|
ALEMBIC |
213444 |
007 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
4.5MG |
Prescription |
No |
No |
AB |
2022/02/03
|
NOVAST LABS |
活性成分:PRAMIPEXOLE DIHYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:2.25MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022421 |
006 |
NDA |
MIRAPEX ER |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
2.25MG |
Discontinued |
Yes |
No |
AB |
2011/06/17
|
BOEHRINGER INGELHEIM |
202206 |
004 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
2.25MG |
Discontinued |
No |
No |
AB |
2014/02/06
|
ENDO OPERATIONS |
206156 |
004 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
2.25MG |
Prescription |
No |
No |
AB |
2016/06/24
|
MACLEODS PHARMS LTD |
203615 |
001 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
2.25MG |
Prescription |
No |
No |
AB |
2016/10/14
|
ACTAVIS ELIZABETH |
202891 |
004 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
2.25MG |
Prescription |
No |
No |
AB |
2017/12/12
|
ZYDUS PHARMS |
204518 |
004 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
2.25MG |
Prescription |
No |
No |
AB |
2019/01/02
|
ALEMBIC |
213444 |
004 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
2.25MG |
Prescription |
No |
No |
AB |
2022/02/03
|
NOVAST LABS |
活性成分:PRAMIPEXOLE DIHYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:3.75MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022421 |
007 |
NDA |
MIRAPEX ER |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3.75MG |
Discontinued |
Yes |
No |
AB |
2011/06/17
|
BOEHRINGER INGELHEIM |
202206 |
006 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3.75MG |
Discontinued |
No |
No |
AB |
2014/02/06
|
ENDO OPERATIONS |
203615 |
002 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3.75MG |
Prescription |
No |
No |
AB |
2017/01/03
|
ACTAVIS ELIZABETH |
206156 |
007 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3.75MG |
Prescription |
No |
No |
AB |
2017/01/23
|
MACLEODS PHARMS LTD |
202891 |
006 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3.75MG |
Prescription |
No |
No |
AB |
2017/12/12
|
ZYDUS PHARMS |
204518 |
006 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3.75MG |
Prescription |
No |
No |
AB |
2019/01/02
|
ALEMBIC |
213444 |
006 |
ANDA |
PRAMIPEXOLE DIHYDROCHLORIDE |
PRAMIPEXOLE DIHYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
3.75MG |
Prescription |
No |
No |
AB |
2022/02/03
|
NOVAST LABS |